NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Motilal Oswal Report
Aditya Birla Capital Ltd. has exhibited a significant improvement in operational metrics across all business segments in FY24. FY25 will see an uptick in growth, lower credit costs, and better return ratios.
The asset management business is likely to churn out better profitability, driven by an improvement in revenue as well as cost rationalisation. Value of new business margin and persistency margin in the Life Insurance business continue to improve. The drag on consolidated PAT from other segments, such as health insurance, will decline, improving overall profitability.
We expect a consolidated profit after tax compound annual growth rate of ~16% over FY24-26E. The thrust on cross-selling, investments in digital, and leveraging ‘One ABC’ will lead to healthy return ratios, even as we build in a consolidated return on equity of ~14% in FY26.
We reiterate our Buy rating on the stock with our revised SoTP (March-26E)- based target price of Rs 260.
Click on the attachment to read the full report:
Also Read: Jindal Steel And Power Q4 Results Review - Near Term Hiccups In Volume Growth: Prabhudas Lilladher
DISCLAIMER
This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
RECOMMENDED FOR YOU

Ambuja Cement — Nirmal Bang's Top Stock Bet In Cement Sector; Q1 Results Preview


Laurus Labs, Supriya Lifesciences, Divi’s Labs— DRChoksey's Top Stock Picks In Pharma Pack; Q1 Results Preview


Fine Organics, PCBL — PL Capital's Top Stock Picks In Chemical Sector

Rupee Weakens Against Dollar At Close
